Adults aged 50-59 years of age
Showing 1 - 25 of >10,000
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- CVI-VZV-001
- Shingrix
-
Seoul, Eunpyeong-gu, Korea, Republic of
- +1 more
Nov 20, 2023
COVID-19 Trial in Nanjing, Hangzhou (20 µg dose of SYS6006, 30 µg dose of SYS6006, Placebo)
Enrolling by invitation
- SARS-CoV-2
- 20 μg dose of SYS6006；30 μg dose of SYS6006
- Placebo
-
Nanjing, Jiangsu, China
- +1 more
Dec 20, 2022
Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,
Not yet recruiting
- Herpes Zoster
- Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
- +5 more
-
Halifax, CanadaCanadian Center for Vaccinology
Aug 6, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- Placebo
-
Daphne, Alabama
- +56 more
Jan 20, 2023
Categories and Attaining LDL-C Targets in Middle Eastern Adults
Not yet recruiting
- Atherosclerotic Cardiovascular Risk
- Low-density-lipoprotein (LDL) Cholesterol
- (no location specified)
Feb 16, 2023
Traumatic Brain Injury, Cerebral Edema Trial (ABX-101 1mg, ABX-101 2mg)
Not yet recruiting
- Traumatic Brain Injury
- Cerebral Edema
- ABX-101 1mg
- ABX-101 2mg
- (no location specified)
Oct 20, 2023
COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))
Recruiting
- COVID-19
- Recombinant new coronavirus vaccine (CHO cell)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 10, 2022
Herpes Zoster Trial in Huaian, Lianyungang, Shanghai (RZV, Placebo)
Active, not recruiting
- Herpes Zoster
- RZV
- Placebo
-
Huaian, Jiangsu, China
- +5 more
Jan 20, 2023
Herpes Zoster Trial in India (HZ/su, Placebo)
Active, not recruiting
- Herpes Zoster
- HZ/su
- Placebo
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Jan 6, 2023
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
Dengue Trial (V181, Butantan-DV)
Not yet recruiting
- Dengue
- V181
- Butantan-DV
- (no location specified)
Jan 24, 2023
COVID-19 Trial in Herston (UQSC2 Vaccine, NVX-CoV2373 vaccine)
Not yet recruiting
- COVID-19
- UQSC2 Vaccine
- NVX-CoV2373 vaccine
-
Herston, Queensland, AustraliaQ-Pharm Pty Ltd (Nucleus Network Brisbane)
Mar 8, 2023
Influenza Immunization Trial (Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH)
Not yet recruiting
- Influenza Immunization
- Quadrivalent Recombinant influenza vaccine (RIV4) season/2022-2023/NH
- (no location specified)
Aug 22, 2022
COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)
Active, not recruiting
- COVID-19
- Vaccine Reaction
- LYB001
- CoronaVac
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023
Sexually Transmitted Diseases Trial in Lenexa (NgG low dose investigational vaccine, NgG medium dose investigational vaccine,
Recruiting
- Sexually Transmitted Diseases
- NgG low dose investigational vaccine
- +5 more
-
Lenexa, KansasGSK Investigational Site
Jan 6, 2023
Respiratory Syncytial Virus Infection Prevention Trial in Worldwide (Ad26.RSV.preF-based Vaccine, Placebo)
Completed
- Respiratory Syncytial Virus Infection Prevention
- Ad26.RSV.preF-based Vaccine
- Placebo
-
Coral Gables, Florida
- +22 more
Sep 27, 2022
Herpes Zoster, Shingles Trial in San Antonio (CRV-101 Vaccine Antigen High Dose, CRV-101 Vaccine Antigen Low Dose, Shingrix)
Recruiting
- Herpes Zoster
- Shingles
- CRV-101 Vaccine Antigen High Dose
- +2 more
-
San Antonio, TexasClinical Trials of Texas
Mar 22, 2022
Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections Trial in Puer (PBPV, PPV23)
Not yet recruiting
- Pneumonia
- +2 more
- PBPV
- PPV23
-
Puer, Yunnan, ChinaLancang Lahu Autonomous County Center for Disease Control and Pr
Nov 10, 2022
Respiratory Syncytial Viruses Trial in Canada, United Kingdom, United States (RSVPreF3 OA investigational vaccine, HZ/su
Not yet recruiting
- Respiratory Syncytial Viruses
- RSVPreF3 OA investigational vaccine
- HZ/su vaccine
-
Daphne, Alabama
- +23 more
Jul 21, 2023
SARS-CoV-2 Trial in Changsha, Xiangtan (SARS-CoV-2 (LVRNA009) 50µg group, SARS-CoV-2 (LVRNA009) 100µg group, Placebo)
Active, not recruiting
- SARS-CoV-2
- SARS-CoV-2 (LVRNA009) 50μg group
- +2 more
-
Changsha, Hunan, China
- +1 more
Jul 19, 2022
Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile
Completed
- Clostridium Infections
- C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
- +2 more
-
Gent, BelgiumGSK Investigational Site
Jun 9, 2022
Respiratory Syncytial Virus Infection Trial in Puerto Rico, United States (RSV mRNA LNP CL-0059 Low dose, RSV mRNA LNP CL-0137
Recruiting
- Respiratory Syncytial Virus Infection
- RSV mRNA LNP CL-0059 Low dose
- +6 more
-
Hollywood, Florida
- +4 more
Jan 17, 2023
Healthy Trial in Hollywood, Atlanta, Omaha (IVX-121, IVX-241, Placebo)
Recruiting
- Healthy
- IVX-121
- +3 more
-
Hollywood, Florida
- +2 more
Dec 22, 2022
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023